메뉴 건너뛰기




Volumn 12, Issue 2, 2011, Pages 277-291

Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response

Author keywords

antipsychotic response; association study; clozapine response; dopamine receptor gene; gene gene interaction; GRIN1; GRIN2A; GRIN2B; NMDA receptor subunit gene; schizophrenia

Indexed keywords

CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; SERINE;

EID: 79951920911     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.182     Document Type: Article
Times cited : (22)

References (97)
  • 1
    • 0024431679 scopus 로고
    • The current status of neuroleptic therapy
    • Kane JM: The current status of neuroleptic therapy. J. Clin. Psychiatry 50(9), 322-328 (1989).
    • (1989) J. Clin. Psychiatry , vol.50 , Issue.9 , pp. 322-328
    • Kane, J.M.1
  • 2
    • 0035065899 scopus 로고    scopus 로고
    • Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
    • Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B: Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am. J. Psychiatry 158(4), 518-526 (2001).
    • (2001) Am. J. Psychiatry , vol.158 , Issue.4 , pp. 518-526
    • Chakos, M.1    Lieberman, J.2    Hoffman, E.3    Bradford, D.4    Sheitman, B.5
  • 3
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
    • Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45(9), 789-796 (1988).
    • (1988) Arch. Gen. Psychiatry , vol.45 , Issue.9 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3    Meltzer, H.4
  • 4
    • 0031417026 scopus 로고    scopus 로고
    • Treatment-resistant schizophrenia - The role of clozapine
    • Meltzer HY: Treatment-resistant schizophrenia - the role of clozapine. Curr. Med. Res. Opin. 14(1), 1-20 (1997).
    • (1997) Curr. Med. Res. Opin. , vol.14 , Issue.1 , pp. 1-20
    • Meltzer, H.Y.1
  • 5
    • 0033008580 scopus 로고    scopus 로고
    • Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials
    • Wahlbeck K, Cheine M, Essali A, Adams C: Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am. J. Psychiatry 156(7), 990-999 (1999).
    • (1999) Am. J. Psychiatry , vol.156 , Issue.7 , pp. 990-999
    • Wahlbeck, K.1    Cheine, M.2    Essali, A.3    Adams, C.4
  • 6
    • 0001962034 scopus 로고    scopus 로고
    • Receptor profile of antipsychotics
    • Ellenbroek BA, Cools AR (Eds). Bikhauser Verlag, Basel, Switzerland
    • Leysen JE: Receptor profile of antipsychotics. In:Atypical Antipsychotics , Ellenbroek BA, Cools AR (Eds). Bikhauser Verlag, Basel, Switzerland, 57-81 (2000).
    • (2000) Atypical Antipsychotics , pp. 57-81
    • Leysen, J.E.1
  • 7
    • 11844286960 scopus 로고    scopus 로고
    • Mechanisms of action of second generation antipsychotic drugs in schizophrenia: Insights from brain imaging studies
    • Abi-Dargham A, Laruelle M: Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur. Psychiatry 20(1), 15-27 (2005).
    • (2005) Eur. Psychiatry , vol.20 , Issue.1 , pp. 15-27
    • Abi-Dargham, A.1    Laruelle, M.2
  • 8
    • 0025286232 scopus 로고
    • Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress
    • Deutch AY, Clark WA, Roth RH: Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521(1-2), 311-315 (1990).
    • (1990) Brain Res. , vol.521 , Issue.1-2 , pp. 311-315
    • Deutch, A.Y.1    Clark, W.A.2    Roth, R.H.3
  • 9
    • 0036177183 scopus 로고    scopus 로고
    • Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
    • Meyer-Lindenberg A, Miletich RS, Kohn PD et al.: Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 5(3), 267-271 (2002).
    • (2002) Nat. Neurosci. , vol.5 , Issue.3 , pp. 267-271
    • Meyer-Lindenberg, A.1    Miletich, R.S.2    Kohn, P.D.3
  • 10
    • 0019190758 scopus 로고
    • Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
    • Pycock CJ, Kerwin RW, Carter CJ: Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286(5768), 74-76 (1980).
    • (1980) Nature , vol.286 , Issue.5768 , pp. 74-76
    • Pycock, C.J.1    Kerwin, R.W.2    Carter, C.J.3
  • 11
    • 0023215296 scopus 로고
    • Implications of normal brain development for the pathogenesis of schizophrenia
    • Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44(7), 660-669 (1987).
    • (1987) Arch. Gen. Psychiatry , vol.44 , Issue.7 , pp. 660-669
    • Weinberger, D.R.1
  • 12
    • 0023732007 scopus 로고
    • Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in huntington's disease and schizophrenia
    • Joyce JN, Lexow N, Bird E, Winokur A: Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in huntington's disease and schizophrenia. Synapse 2(5), 546-557 (1988).
    • (1988) Synapse , vol.2 , Issue.5 , pp. 546-557
    • Joyce, J.N.1    Lexow, N.2    Bird, E.3    Winokur, A.4
  • 13
    • 26644464161 scopus 로고    scopus 로고
    • Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations
    • Rationale and single polymorphism association results for DRD2 polymorphisms used in the present study
    • Hwang R, Shinkai T, De Luca V et al.: Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl.) 181(1), 179-187 (2005). Rationale and single polymorphism association results for DRD2 polymorphisms used in the present study.
    • (2005) Psychopharmacology (Berl.) , vol.181 , Issue.1 , pp. 179-187
    • Hwang, R.1    Shinkai, T.2    De Luca, V.3
  • 14
    • 34548854787 scopus 로고    scopus 로고
    • Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response
    • Detailed description of the clinical sample, rationale and single polymorphism association results for DRD1 polymorphisms used in the present study
    • Hwang R, Shinkai T, De Luca V et al.: Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J. Psychopharmacol. 21(7), 718-727 (2007). Detailed description of the clinical sample, rationale and single polymorphism association results for DRD1 polymorphisms used in the present study.
    • (2007) J. Psychopharmacol. , vol.21 , Issue.7 , pp. 718-727
    • Hwang, R.1    Shinkai, T.2    De Luca, V.3
  • 15
    • 77952887880 scopus 로고    scopus 로고
    • Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: Exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
    • Rationale and single polymorphism association results for DRD3 polymorphisms used in the present study
    • Hwang R, Zai C, Tiwari A et al.: Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Pharmacogenomics J. 10(3), 200-218 (2009). Rationale and single polymorphism association results for DRD3 polymorphisms used in the present study.
    • (2009) Pharmacogenomics J. , vol.10 , Issue.3 , pp. 200-218
    • Hwang, R.1    Zai, C.2    Tiwari, A.3
  • 17
    • 0031800006 scopus 로고    scopus 로고
    • M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice
    • Wang RY, Liang X: M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Neuropsychopharmacology 19(1), 74-85 (1998).
    • (1998) Neuropsychopharmacology , vol.19 , Issue.1 , pp. 74-85
    • Wang, R.Y.1    Liang, X.2
  • 18
    • 0030881619 scopus 로고    scopus 로고
    • Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro
    • Arvanov VL, Liang X, Schwartz J, Grossman S, Wang RY: Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J. Pharmacol. Exp. Ther. 283(1), 226-234 (1997).
    • (1997) J. Pharmacol. Exp. Ther. , vol.283 , Issue.1 , pp. 226-234
    • Arvanov, V.L.1    Liang, X.2    Schwartz, J.3    Grossman, S.4    Wang, R.Y.5
  • 19
    • 0025952455 scopus 로고
    • Recent advances in the phencyclidine model of schizophrenia
    • Javitt DC, Zukin SR: Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148(10), 1301-1308 (1991).
    • (1991) Am. J. Psychiatry , vol.148 , Issue.10 , pp. 1301-1308
    • Javitt, D.C.1    Zukin, S.R.2
  • 20
    • 0028850552 scopus 로고
    • Glutamate receptor dysfunction and schizophrenia
    • Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52(12), 998-1007 (1995).
    • (1995) Arch. Gen. Psychiatry , vol.52 , Issue.12 , pp. 998-1007
    • Olney, J.W.1    Farber, N.B.2
  • 21
    • 0029557350 scopus 로고
    • Glutamate pharmacology and the treatment of schizophrenia: Current status and future directions
    • Tamminga CA, Holcomb HH, Gao XM, Lahti AC: Glutamate pharmacology and the treatment of schizophrenia: Current status and future directions. Int. Clin. Psychopharmacol. 10(Suppl. 3), 29-37 (1995).
    • (1995) Int. Clin. Psychopharmacol. , vol.10 , Issue.SUPPL. 3 , pp. 29-37
    • Tamminga, C.A.1    Holcomb, H.H.2    Gao, X.M.3    Lahti, A.C.4
  • 22
    • 30544437565 scopus 로고    scopus 로고
    • Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function
    • Duncan GE, Moy SS, Lieberman JA, Koller BH: Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl.) 184(2), 190-200 (2006).
    • (2006) Psychopharmacology (Berl.) , vol.184 , Issue.2 , pp. 190-200
    • Duncan, G.E.1    Moy, S.S.2    Lieberman, J.A.3    Koller, B.H.4
  • 23
    • 33947511870 scopus 로고    scopus 로고
    • Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response
    • Levin ED, Caldwell DP, Perraut C: Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol. Biochem. Behav. 86(3), 597-605 (2007).
    • (2007) Pharmacol. Biochem. Behav. , vol.86 , Issue.3 , pp. 597-605
    • Levin, E.D.1    Caldwell, D.P.2    Perraut, C.3
  • 24
    • 44449175118 scopus 로고    scopus 로고
    • Repeated low dose of phencyclidine administration impairs spatial learning in mice: Blockade by clozapine but not by haloperidol
    • Beraki S, Kuzmin A, Tai F, Ogren SO: Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol. Eur. Neuropsychopharmacol. 18(7), 486-497 (2008).
    • (2008) Eur. Neuropsychopharmacol. , vol.18 , Issue.7 , pp. 486-497
    • Beraki, S.1    Kuzmin, A.2    Tai, F.3    Ogren, S.O.4
  • 25
    • 0030608074 scopus 로고    scopus 로고
    • Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity
    • Farber NB, Foster J, Duhan NL, Olney JW: Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr. Res. 21(1), 33-37 (1996).
    • (1996) Schizophr. Res. , vol.21 , Issue.1 , pp. 33-37
    • Farber, N.B.1    Foster, J.2    Duhan, N.L.3    Olney, J.W.4
  • 26
    • 0027249274 scopus 로고
    • Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity
    • Farber NB, Price MT, Labruyere J et al.: Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol. Psychiatry 34(1-2), 119-121 (1993).
    • (1993) Biol. Psychiatry , vol.34 , Issue.1-2 , pp. 119-121
    • Farber, N.B.1    Price, M.T.2    Labruyere, J.3
  • 27
    • 38349167489 scopus 로고    scopus 로고
    • Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: Differential efficacy depending on the stage of the task at which they are administered
    • Gaisler-Salomon I, Diamant L, Rubin C, Weiner I: Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology (Berl.) 196(2), 255-267 (2008).
    • (2008) Psychopharmacology (Berl.) , vol.196 , Issue.2 , pp. 255-267
    • Gaisler-Salomon, I.1    Diamant, L.2    Rubin, C.3    Weiner, I.4
  • 28
    • 0028170896 scopus 로고
    • New mechanisms of excitatory transmitter neurotoxicity
    • Olney JW: New mechanisms of excitatory transmitter neurotoxicity. J. Neural. Transm. Suppl. 43, 47-51 (1994).
    • (1994) J. Neural. Transm. Suppl. , vol.43 , pp. 47-51
    • Olney, J.W.1
  • 29
    • 0028089726 scopus 로고
    • Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity
    • Olney JW, Farber NB: Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. J. Clin. Psychiatry 55(Suppl. B), 43-46 (1994).
    • (1994) J. Clin. Psychiatry , vol.55 , Issue.SUPPL. B , pp. 43-46
    • Olney, J.W.1    Farber, N.B.2
  • 30
    • 0033588463 scopus 로고    scopus 로고
    • Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: A possible model for the screening of atypical antipsychotics
    • Zhang W, Pouzet B, Jongen-Relo AL, Weiner I, Feldon J: Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport 10(12), 2533-2538 (1999).
    • (1999) Neuroreport , vol.10 , Issue.12 , pp. 2533-2538
    • Zhang, W.1    Pouzet, B.2    Jongen-Relo, A.L.3    Weiner, I.4    Feldon, J.5
  • 31
    • 0029030343 scopus 로고
    • Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonistinduced behaviors
    • Corbett R, Camacho F, Woods AT et al.: Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonistinduced behaviors. Psychopharmacology (Berl.) 120(1), 67-74 (1995).
    • (1995) Psychopharmacology (Berl.) , vol.120 , Issue.1 , pp. 67-74
    • Corbett, R.1    Camacho, F.2    Woods, A.T.3
  • 32
    • 25144509345 scopus 로고    scopus 로고
    • Mechanism of action of antipsychotic drugs: From dopamine D(2) receptor antagonism to glutamate NMDA facilitation
    • Functional interactions between glutamatergic and dopamine elements unify the key alterations postulated in schizophrenia
    • Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A: Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin. Ther. 27(Suppl. A), S16-S24 (2005). Functional interactions between glutamatergic and dopamine elements unify the key alterations postulated in schizophrenia.
    • (2005) Clin. Ther. , vol.27 , Issue.SUPPL. A
    • Laruelle, M.1    Frankle, W.G.2    Narendran, R.3    Kegeles, L.S.4    Abi-Dargham, A.5
  • 34
    • 0034307054 scopus 로고    scopus 로고
    • Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
    • Kegeles LS, Abi-Dargham A, Zea-Ponce Y et al.: Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol. Psychiatry 48(7), 627-640 (2000).
    • (2000) Biol. Psychiatry , vol.48 , Issue.7 , pp. 627-640
    • Kegeles, L.S.1    Abi-Dargham, A.2    Zea-Ponce, Y.3
  • 35
    • 3543083733 scopus 로고    scopus 로고
    • Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal
    • Lee SP, So CH, Rashid AJ et al.: Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 279(34), 35671-35678 (2004).
    • (2004) J. Biol. Chem. , vol.279 , Issue.34 , pp. 35671-35678
    • Lee, S.P.1    So, C.H.2    Rashid, A.J.3
  • 36
    • 27744484748 scopus 로고    scopus 로고
    • Dopamine receptor oligomerization visualized in living cells
    • O'Dowd BF, Ji X, Alijaniaram M et al.: Dopamine receptor oligomerization visualized in living cells. J. Biol. Chem. 280(44), 37225-37235 (2005).
    • (2005) J. Biol. Chem. , vol.280 , Issue.44 , pp. 37225-37235
    • O'Dowd, B.F.1    Ji, X.2    Alijaniaram, M.3
  • 37
    • 23944467820 scopus 로고    scopus 로고
    • D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor
    • So CH, Varghese G, Curley KJ et al.: D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol. Pharmacol. 68(3), 568-578 (2005).
    • (2005) Mol. Pharmacol. , vol.68 , Issue.3 , pp. 568-578
    • So, C.H.1    Varghese, G.2    Curley, K.J.3
  • 38
    • 33846328669 scopus 로고    scopus 로고
    • D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum
    • Rashid AJ, So CH, Kong MM et al.: D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl Acad. Sci. USA 104(2), 654-659 (2007).
    • (2007) Proc. Natl Acad. Sci. USA , vol.104 , Issue.2 , pp. 654-659
    • Rashid, A.J.1    So, C.H.2    Kong, M.M.3
  • 39
    • 45649085857 scopus 로고    scopus 로고
    • Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization
    • Fiorentini C, Busi C, Gorruso E, Gotti C, Spano P, Missale C: Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol. Pharmacol. 74(1), 59-69 (2008).
    • (2008) Mol. Pharmacol. , vol.74 , Issue.1 , pp. 59-69
    • Fiorentini, C.1    Busi, C.2    Gorruso, E.3    Gotti, C.4    Spano, P.5    Missale, C.6
  • 40
    • 54449099573 scopus 로고    scopus 로고
    • Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum
    • Marcellino D, Ferre S, Casado V et al.: Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J. Biol. Chem. 283(38), 26016-26025 (2008).
    • (2008) J. Biol. Chem. , vol.283 , Issue.38 , pp. 26016-26025
    • Marcellino, D.1    Ferre, S.2    Casado, V.3
  • 41
    • 0142241355 scopus 로고    scopus 로고
    • Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole
    • Maggio R, Scarselli M, Novi F, Millan MJ, Corsini GU: Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J. Neurochem. 87(3), 631-641 (2003).
    • (2003) J. Neurochem. , vol.87 , Issue.3 , pp. 631-641
    • Maggio, R.1    Scarselli, M.2    Novi, F.3    Millan, M.J.4    Corsini, G.U.5
  • 42
    • 34547451141 scopus 로고    scopus 로고
    • Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: Potential role of heterodimer formation
    • Novi F, Millan MJ, Corsini GU, Maggio R: Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. J. Neurochem. 102(4), 1410-1424 (2007).
    • (2007) J. Neurochem. , vol.102 , Issue.4 , pp. 1410-1424
    • Novi, F.1    Millan, M.J.2    Corsini, G.U.3    Maggio, R.4
  • 43
    • 0035839599 scopus 로고    scopus 로고
    • D2/D3 dopamine receptor heterodimers exhibit unique functional properties
    • Scarselli M, Novi F, Schallmach E et al.: D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 276(32), 30308-30314 (2001).
    • (2001) J. Biol. Chem. , vol.276 , Issue.32 , pp. 30308-30314
    • Scarselli, M.1    Novi, F.2    Schallmach, E.3
  • 44
    • 18644386370 scopus 로고    scopus 로고
    • Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor
    • Lee FJ, Xue S, Pei L et al.: Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111(2), 219-230 (2002).
    • (2002) Cell , vol.111 , Issue.2 , pp. 219-230
    • Lee, F.J.1    Xue, S.2    Pei, L.3
  • 45
    • 0038165500 scopus 로고    scopus 로고
    • Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors
    • Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C: Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278(22), 20196-20202 (2003).
    • (2003) J. Biol. Chem. , vol.278 , Issue.22 , pp. 20196-20202
    • Fiorentini, C.1    Gardoni, F.2    Spano, P.3    Di Luca, M.4    Missale, C.5
  • 46
    • 34547664367 scopus 로고    scopus 로고
    • Modulation of D2R-NR2B interactions in response to cocaine
    • Liu XY, Chu XP, Mao LM et al.: Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52(5), 897-909 (2006).
    • (2006) Neuron , vol.52 , Issue.5 , pp. 897-909
    • Liu, X.Y.1    Chu, X.P.2    Mao, L.M.3
  • 47
    • 57849133982 scopus 로고    scopus 로고
    • Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization - A working hypothesis
    • Dziedzicka-Wasylewska M, Faron-Gorecka A, Gorecki A, Kusemider M: Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization - a working hypothesis. Pharmacol. Rep. 60(5), 581-587 (2008).
    • (2008) Pharmacol. Rep. , vol.60 , Issue.5 , pp. 581-587
    • Dziedzicka-Wasylewska, M.1    Faron-Gorecka, A.2    Gorecki, A.3    Kusemider, M.4
  • 49
    • 0026721811 scopus 로고
    • Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
    • Monyer H, Sprengel R, Schoepfer R et al.: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256(5060), 1217-1221 (1992).
    • (1992) Science , vol.256 , Issue.5060 , pp. 1217-1221
    • Monyer, H.1    Sprengel, R.2    Schoepfer, R.3
  • 51
    • 0026717250 scopus 로고
    • Molecular diversity of the NMDA receptor channel
    • Kutsuwada T, Kashiwabuchi N, Mori H et al.: Molecular diversity of the NMDA receptor channel. Nature 358(6381), 36-41 (1992).
    • (1992) Nature , vol.358 , Issue.6381 , pp. 36-41
    • Kutsuwada, T.1    Kashiwabuchi, N.2    Mori, H.3
  • 52
    • 13344278706 scopus 로고    scopus 로고
    • Monozygotic twins concordant for response to clozapine
    • Vojvoda D, Grimmell K, Sernyak M, Mazure CM: Monozygotic twins concordant for response to clozapine. Lancet 347(8993), 61 (1996).
    • (1996) Lancet , vol.347 , Issue.8993 , pp. 61
    • Vojvoda, D.1    Grimmell, K.2    Sernyak, M.3    Mazure, C.M.4
  • 53
    • 0035703938 scopus 로고    scopus 로고
    • Association analysis for NMDA receptor subunit 2b (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia
    • Hong CJ, Yu YW, Lin CH, Cheng CY, Tsai SJ: Association analysis for NMDA receptor subunit 2b (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr. Genet. 11(4), 219-222 (2001).
    • (2001) Psychiatr. Genet. , vol.11 , Issue.4 , pp. 219-222
    • Hong, C.J.1    Yu, Y.W.2    Lin, C.H.3    Cheng, C.Y.4    Tsai, S.J.5
  • 54
    • 0345411335 scopus 로고    scopus 로고
    • The ubiquitous nature of epistasis in determining susceptibility to common human diseases
    • Gene-gene interaction is a ubiquitous component of the genetic architecture of common human diseases and complex interactions are more important than the independent main effects of individual susceptibility genes
    • Moore JH: The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56(1-3), 73-82 (2003). Gene-gene interaction is a ubiquitous component of the genetic architecture of common human diseases and complex interactions are more important than the independent main effects of individual susceptibility genes.
    • (2003) Hum. Hered. , vol.56 , Issue.1-3 , pp. 73-82
    • Moore, J.H.1
  • 55
    • 2442424229 scopus 로고    scopus 로고
    • Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics
    • Anttila S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E: Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics. Pharmacogenetics 14(5), 303-307 (2004).
    • (2004) Pharmacogenetics , vol.14 , Issue.5 , pp. 303-307
    • Anttila, S.1    Illi, A.2    Kampman, O.3    Mattila, K.M.4    Lehtimaki, T.5    Leinonen, E.6
  • 56
    • 77952422367 scopus 로고    scopus 로고
    • GSNO reductase and b2-adrenergic receptor gene-gene interaction: Bronchodilator responsiveness to albuterol
    • Choudhry S, Que LG, Yang Z et al.: GSNO reductase and b2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenet. Genomics 20(6), 351-358 (2010).
    • (2010) Pharmacogenet. Genomics , vol.20 , Issue.6 , pp. 351-358
    • Choudhry, S.1    Que, L.G.2    Yang, Z.3
  • 58
    • 33645993851 scopus 로고    scopus 로고
    • Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment
    • Hwang R, Shinkai T, Deluca V et al.: Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment. Eur. Neuropsychopharmacol. 16(4), 248-259 (2006).
    • (2006) Eur. Neuropsychopharmacol. , vol.16 , Issue.4 , pp. 248-259
    • Hwang, R.1    Shinkai, T.2    Deluca, V.3
  • 59
    • 0026080111 scopus 로고
    • A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
    • Lahiri DK, Nurnberger JI Jr.: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19(19), 5444 (1991).
    • (1991) Nucleic Acids Res. , vol.19 , Issue.19 , pp. 5444
    • Lahiri, D.K.1    Nurnberger Jr., J.I.2
  • 60
    • 0037382656 scopus 로고    scopus 로고
    • Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia
    • Begni S, Moraschi S, Bignotti S et al.: Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol. Psychiatry 53(7), 617-619 (2003).
    • (2003) Biol. Psychiatry , vol.53 , Issue.7 , pp. 617-619
    • Begni, S.1    Moraschi, S.2    Bignotti, S.3
  • 61
    • 69249231191 scopus 로고    scopus 로고
    • Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population
    • Galehdari H, Pooryasin A, Foroughmand A, Daneshmand S, Saadat M: Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. J. Mol. Neurosci. 38(2), 178-181 (2009).
    • (2009) J. Mol. Neurosci. , vol.38 , Issue.2 , pp. 178-181
    • Galehdari, H.1    Pooryasin, A.2    Foroughmand, A.3    Daneshmand, S.4    Saadat, M.5
  • 62
    • 34548309202 scopus 로고    scopus 로고
    • Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample
    • Georgi A, Jamra RA, Klein K et al.: Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr. Genet. 17(5), 308-310 (2007).
    • (2007) Psychiatr. Genet. , vol.17 , Issue.5 , pp. 308-310
    • Georgi, A.1    Jamra, R.A.2    Klein, K.3
  • 63
    • 0042821620 scopus 로고    scopus 로고
    • N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses
    • Martucci L, Wong AH, Trakalo J et al.: N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 119B(1), 24-27 (2003).
    • (2003) Am. J. Med. Genet. B. Neuropsychiatr. Genet. , vol.119 B , Issue.1 , pp. 24-27
    • Martucci, L.1    Wong, A.H.2    Trakalo, J.3
  • 64
    • 33645329090 scopus 로고    scopus 로고
    • Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia
    • Zhao X, Li H, Shi Y et al.: Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol. Psychiatry 59(8), 747-753 (2006).
    • (2006) Biol. Psychiatry , vol.59 , Issue.8 , pp. 747-753
    • Zhao, X.1    Li, H.2    Shi, Y.3
  • 65
    • 12444281048 scopus 로고    scopus 로고
    • A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2a subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia
    • Promotor activity of plasmid constructs with repeat lengths of 25 or more were significantly lower than those with less than 25 repeats
    • Itokawa M, Yamada K, Yoshitsugu K et al.: A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2a subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics 13(5), 271-278 (2003). Promotor activity of plasmid constructs with repeat lengths of 25 or more were significantly lower than those with less than 25 repeats.
    • (2003) Pharmacogenetics , vol.13 , Issue.5 , pp. 271-278
    • Itokawa, M.1    Yamada, K.2    Yoshitsugu, K.3
  • 66
    • 14844358507 scopus 로고    scopus 로고
    • Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia
    • Iwayama-Shigeno Y, Yamada K, Itokawa M et al.: Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia. Neurosci. Lett. 378(2), 102-105 (2005).
    • (2005) Neurosci. Lett. , vol.378 , Issue.2 , pp. 102-105
    • Iwayama-Shigeno, Y.1    Yamada, K.2    Itokawa, M.3
  • 67
    • 12244289624 scopus 로고    scopus 로고
    • Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia
    • Luciferase reporter activity of plasmids with the GRIN2B T-200G T allele were significantly upregulated compared with that of the G allele
    • Miyatake R, Furukawa A, Suwaki H: Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol. Psychiatry 7(10), 1101-1106 (2002). Luciferase reporter activity of plasmids with the GRIN2B T-200G T allele were significantly upregulated compared with that of the G allele.
    • (2002) Mol. Psychiatry , vol.7 , Issue.10 , pp. 1101-1106
    • Miyatake, R.1    Furukawa, A.2    Suwaki, H.3
  • 68
    • 33646535427 scopus 로고    scopus 로고
    • N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels
    • Martucci L, Wong Ah, De Luca V et al.: N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels. Schizophr. Res. 84(2-3), 214-221 (2006).
    • (2006) Schizophr. Res. , vol.84 , Issue.2-3 , pp. 214-221
    • Martucci, L.1    Ah, W.2    De Luca, V.3
  • 69
    • 0344951296 scopus 로고    scopus 로고
    • D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine
    • Potkin SG, Basile VS, Jin Y et al.: D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol. Psychiatry 8(1), 109-113 (2003).
    • (2003) Mol. Psychiatry , vol.8 , Issue.1 , pp. 109-113
    • Potkin, S.G.1    Basile, V.S.2    Jin, Y.3
  • 70
    • 62749154560 scopus 로고    scopus 로고
    • Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA mir-504
    • Huang W, Li MD: Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA mir-504. Biol. Psychiatry 65(8), 702-705 (2009).
    • (2009) Biol. Psychiatry , vol.65 , Issue.8 , pp. 702-705
    • Huang, W.1    Li, M.D.2
  • 71
    • 0037320652 scopus 로고    scopus 로고
    • Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
    • Duan J, Wainwright MS, Comeron JM et al.: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12(3), 205-216 (2003).
    • (2003) Hum. Mol. Genet. , vol.12 , Issue.3 , pp. 205-216
    • Duan, J.1    Wainwright, M.S.2    Comeron, J.M.3
  • 72
    • 70349102541 scopus 로고    scopus 로고
    • C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity
    • Hirvonen MM, Laakso A, Nagren K, Rinne JO, Pohjalainen T, Hietala J: C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 63(10), 907-912 (2009).
    • (2009) Synapse , vol.63 , Issue.10 , pp. 907-912
    • Hirvonen, M.M.1    Laakso, A.2    Nagren, K.3    Rinne, J.O.4    Pohjalainen, T.5    Hietala, J.6
  • 73
    • 0030933979 scopus 로고    scopus 로고
    • A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
    • Arinami T, Gao M, Hamaguchi H, Toru M: A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum. Mol. Genet. 6(4), 577-582 (1997).
    • (1997) Hum. Mol. Genet. , vol.6 , Issue.4 , pp. 577-582
    • Arinami, T.1    Gao, M.2    Hamaguchi, H.3    Toru, M.4
  • 74
    • 0033009871 scopus 로고    scopus 로고
    • Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
    • Jonsson EG, Nothen MM, Grunhage F et al.: Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4(3), 290-296 (1999).
    • (1999) Mol. Psychiatry , vol.4 , Issue.3 , pp. 290-296
    • Jonsson, E.G.1    Nothen, M.M.2    Grunhage, F.3
  • 75
    • 79951866501 scopus 로고    scopus 로고
    • Allelic variation in the promoter region of the dopamine D2 receptor gene and clozapine response
    • Malhotra AK, Buchanan RW, Kim S, Kestler L, Breier A, Pickar D, Goldman D: Allelic variation in the promoter region of the dopamine D2 receptor gene and clozapine response. J. Sch. Res. 36(1-3), 2 (1999).
    • (1999) J. Sch. Res. , vol.36 , Issue.1-3 , pp. 2
    • Malhotra, A.K.1    Buchanan, R.W.2    Kim, S.3    Kestler, L.4    Breier, A.5    Pickar, D.6    Goldman, D.7
  • 76
    • 0031595664 scopus 로고    scopus 로고
    • The D2 dopamine receptor gene: A review of association studies in alcoholism and phenotypes
    • Noble EP: The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 16(1), 33-45 (1998).
    • (1998) Alcohol , vol.16 , Issue.1 , pp. 33-45
    • Noble, E.P.1
  • 77
    • 0037267659 scopus 로고    scopus 로고
    • Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
    • Ritchie T, Noble EP: Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28(1), 73-82 (2003).
    • (2003) Neurochem. Res. , vol.28 , Issue.1 , pp. 73-82
    • Ritchie, T.1    Noble, E.P.2
  • 78
    • 9844233161 scopus 로고    scopus 로고
    • D2 dopamine receptor gene (DRD2) Taq1a polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele
    • Thompson J, Thomas N, Singleton A et al.: D2 dopamine receptor gene (DRD2) Taq1a polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7(6), 479-484 (1997).
    • (1997) Pharmacogenetics , vol.7 , Issue.6 , pp. 479-484
    • Thompson, J.1    Thomas, N.2    Singleton, A.3
  • 79
    • 0031752522 scopus 로고    scopus 로고
    • The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
    • Pohjalainen T, Rinne JO, Nagren K et al.: The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry 3(3), 256-260 (1998).
    • (1998) Mol. Psychiatry , vol.3 , Issue.3 , pp. 256-260
    • Pohjalainen, T.1    Rinne, J.O.2    Nagren, K.3
  • 80
    • 33746043780 scopus 로고    scopus 로고
    • A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor
    • Jeanneteau F, Funalot B, Jankovic J et al.: A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc. Natl Acad. Sci. USA 103(28), 10753-10758 (2006).
    • (2006) Proc. Natl Acad. Sci. USA , vol.103 , Issue.28 , pp. 10753-10758
    • Jeanneteau, F.1    Funalot, B.2    Jankovic, J.3
  • 81
    • 0030598907 scopus 로고    scopus 로고
    • Proposed schizophrenia-related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki forest virus system
    • Lundstrom K, Turpin MP: Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki forest virus system. Biochem. Biophys. Res. Commun. 225(3), 1068-1072 (1996).
    • (1996) Biochem. Biophys. Res. Commun. , vol.225 , Issue.3 , pp. 1068-1072
    • Lundstrom, K.1    Turpin, M.P.2
  • 82
    • 8744230049 scopus 로고    scopus 로고
    • The Ser9Gly SNP in the dopamine D3 receptor causes a shift from camp related to PGE2 related signal transduction mechanisms in transfected CHO cells
    • Hellstrand M, Danielsen EA, Steen VM, Ekman A, Eriksson E, Nilsson CL: The Ser9Gly SNP in the dopamine D3 receptor causes a shift from camp related to PGE2 related signal transduction mechanisms in transfected CHO cells. J. Med. Genet. 41(11), 867-871 (2004).
    • (2004) J. Med. Genet. , vol.41 , Issue.11 , pp. 867-871
    • Hellstrand, M.1    Danielsen, E.A.2    Steen, V.M.3    Ekman, A.4    Eriksson, E.5    Nilsson, C.L.6
  • 83
    • 0037336692 scopus 로고    scopus 로고
    • Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: Association study and meta-analysis
    • Jonsson EG, Flyckt L, Burgert E et al.: Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr. Genet. 13(1), 1-12 (2003).
    • (2003) Psychiatr. Genet. , vol.13 , Issue.1 , pp. 1-12
    • Jonsson, E.G.1    Flyckt, L.2    Burgert, E.3
  • 84
    • 51249083462 scopus 로고    scopus 로고
    • Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia
    • Labrie V, Lipina T, Roder JC: Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl.) 200(2), 217-230 (2008).
    • (2008) Psychopharmacology (Berl.) , vol.200 , Issue.2 , pp. 217-230
    • Labrie, V.1    Lipina, T.2    Roder, J.C.3
  • 85
    • 34347394551 scopus 로고    scopus 로고
    • Effects of (-)-stepholidine on NMDA receptors: Comparison with haloperidol and clozapine
    • Gu WH, Yang S, Shi WX, Zhen XC, Jin GZ: Effects of (-)-stepholidine on NMDA receptors: comparison with haloperidol and clozapine. Acta. Pharmacol. Sin. 28(7), 953-958 (2007).
    • (2007) Acta. Pharmacol. Sin. , vol.28 , Issue.7 , pp. 953-958
    • Gu, W.H.1    Yang, S.2    Shi, W.X.3    Zhen, X.C.4    Jin, G.Z.5
  • 87
    • 0029910263 scopus 로고    scopus 로고
    • NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia
    • Humphries C, Mortimer A, Hirsch S, De Belleroche J: NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7(12), 2051-2055 (1996).
    • (1996) Neuroreport , vol.7 , Issue.12 , pp. 2051-2055
    • Humphries, C.1    Mortimer, A.2    Hirsch, S.3    De Belleroche, J.4
  • 88
    • 0034094628 scopus 로고    scopus 로고
    • Glutamate receptor expression in schizophrenic brain
    • Meador-Woodruff JH, Healy DJ: Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 31(2-3), 288-294 (2000).
    • (2000) Brain Res. Brain Res. Rev. , vol.31 , Issue.2-3 , pp. 288-294
    • Meador-Woodruff, J.H.1    Healy, D.J.2
  • 89
    • 0033588176 scopus 로고    scopus 로고
    • Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
    • Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98(4), 427-436 (1999).
    • (1999) Cell , vol.98 , Issue.4 , pp. 427-436
    • Mohn, A.R.1    Gainetdinov, R.R.2    Caron, M.G.3    Koller, B.H.4
  • 90
    • 0035862965 scopus 로고    scopus 로고
    • Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor e1 subunit
    • Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T: Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor e1 subunit. J. Neurosci. 21(2), 750-757 (2001).
    • (2001) J. Neurosci. , vol.21 , Issue.2 , pp. 750-757
    • Miyamoto, Y.1    Yamada, K.2    Noda, Y.3    Mori, H.4    Mishina, M.5    Nabeshima, T.6
  • 91
    • 0036174608 scopus 로고    scopus 로고
    • Dimerization: An emerging concept for g protein-coupled receptor ontogeny and function
    • Property of receptors is to form heterodimeric complexes with novel pharmacological, signaling and trafficking characteristics
    • Angers S, Salahpour A, Bouvier M: Dimerization: an emerging concept for g protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435 (2002). Property of receptors is to form heterodimeric complexes with novel pharmacological, signaling and trafficking characteristics.
    • (2002) Annu. Rev. Pharmacol. Toxicol. , vol.42 , pp. 409-435
    • Angers, S.1    Salahpour, A.2    Bouvier, M.3
  • 92
    • 0141788413 scopus 로고    scopus 로고
    • Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia
    • Abi-Dargham A, Moore H: Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9(5), 404-416 (2003).
    • (2003) Neuroscientist , vol.9 , Issue.5 , pp. 404-416
    • Abi-Dargham, A.1    Moore, H.2
  • 93
    • 72649087941 scopus 로고    scopus 로고
    • Heterodimerization of dopamine receptors: New insights into functional and therapeutic significance
    • Maggio R, Aloisi G, Silvano E, Rossi M, Millan MJ: Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. Parkinsonism. Relat. Disord. 15(Suppl. 4), S2-S7 (2009).
    • (2009) Parkinsonism. Relat. Disord. , vol.15 , Issue.SUPPL. 4
    • Maggio, R.1    Aloisi, G.2    Silvano, E.3    Rossi, M.4    Millan, M.J.5
  • 94
    • 37249074554 scopus 로고    scopus 로고
    • A novel dopamine receptor signaling unit in brain: Heterooligomers of D1 and D2 dopamine receptors
    • George SR, O'Dowd BF: A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. ScientificWorldJournal 7, 58-63 (2007).
    • (2007) ScientificWorldJournal , vol.7 , pp. 58-63
    • George, S.R.1    O'Dowd, B.F.2
  • 95
    • 0141853757 scopus 로고    scopus 로고
    • Calcium signaling dysfunction in schizophrenia: A unifying approach
    • Lidow MS: Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Brain Res. Rev. 43(1), 70-84 (2003).
    • (2003) Brain Res. Brain Res. Rev. , vol.43 , Issue.1 , pp. 70-84
    • Lidow, M.S.1
  • 96
    • 67349166946 scopus 로고    scopus 로고
    • Detecting gene-gene interactions that underlie human diseases
    • Utility and challenges in methods for detection and assessment of statistical gene-gene interactions
    • Cordell HJ: Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 10(6), 392-404 (2009). Utility and challenges in methods for detection and assessment of statistical gene-gene interactions.
    • (2009) Nat. Rev. Genet. , vol.10 , Issue.6 , pp. 392-404
    • Cordell, H.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.